These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27308410)

  • 1. Small molecule targeting miR-34a for cancer therapy.
    Xiao Z; Chen Y
    Mol Cell Oncol; 2015; 2(1):e977160. PubMed ID: 27308410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micellar Delivery of miR-34a Modulator Rubone and Paclitaxel in Resistant Prostate Cancer.
    Wen D; Peng Y; Lin F; Singh RK; Mahato RI
    Cancer Res; 2017 Jun; 77(12):3244-3254. PubMed ID: 28428276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxymethyl Dextran-Stabilized Polyethylenimine-Poly(epsilon-caprolactone) Nanoparticles-Mediated Modulation of MicroRNA-34a Expression via Small-Molecule Modulator for Hepatocellular Carcinoma Therapy.
    Deng X; Yin Z; Zhou Z; Wang Y; Zhang F; Hu Q; Yang Y; Lu J; Wu Y; Sheng W; Zeng Y
    ACS Appl Mater Interfaces; 2016 Jul; 8(27):17068-79. PubMed ID: 27300477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Tumor Suppressor MiR-34a Loaded on ZSM-5 Nanozeolite in Hepatocellular Carcinoma: In Vitro and In Vivo Approach.
    Salah Z; Abd El Azeem EM; Youssef HF; Gamal-Eldeen AM; Farrag AR; El-Meliegy E; Soliman B; Elhefnawi M
    Curr Gene Ther; 2019; 19(5):342-354. PubMed ID: 31701846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small-molecule modulator of the tumor-suppressor miR34a inhibits the growth of hepatocellular carcinoma.
    Xiao Z; Li CH; Chan SL; Xu F; Feng L; Wang Y; Jiang JD; Sung JJ; Cheng CH; Chen Y
    Cancer Res; 2014 Nov; 74(21):6236-47. PubMed ID: 25217526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-34a as a Therapeutic Agent against Human Cancer.
    Saito Y; Nakaoka T; Saito H
    J Clin Med; 2015 Nov; 4(11):1951-9. PubMed ID: 26580663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
    Ye J; Li L; Feng P; Wan J; Li J
    Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-34a, as a suppressor, enhance the susceptibility of gastric cancer cell to luteolin by directly targeting HK1.
    Zhou Y; Ding BZ; Lin YP; Wang HB
    Gene; 2018 Feb; 644():56-65. PubMed ID: 29054762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-34a functions as a tumor suppressor by directly targeting oncogenic PLCE1 in Kazakh esophageal squamous cell carcinoma.
    Cui XB; Peng H; Li RR; Mu JQ; Yang L; Li N; Liu CX; Hu JM; Li SG; Wei Y; Laibo-Yin ; Zhou H; Li F; Chen YZ
    Oncotarget; 2017 Nov; 8(54):92454-92469. PubMed ID: 29190930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the diagnostic and therapeutic roles of non-coding RNA and cell proliferation related gene association in hepatocellular carcinoma.
    Ahmed MY; Salah MM; Kassim SK; Abdelaal A; Elayat WM; Mohamed DA; Fouly AE; Abu-Zahra FAE
    Gene; 2019 Jul; 706():97-105. PubMed ID: 31034943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulation of miR-34a and Its Chaperon Hsp70 in Hepatitis C virus-Induced Liver Cirrhosis and Hepatocellular Carcinoma Patients.
    Shehata RH; Abdelmoneim SS; Osman OA; Hasanain AF; Osama A; Abdelmoneim SS; Toraih EA
    Asian Pac J Cancer Prev; 2017 Sep; 18(9):2395-2401. PubMed ID: 28950684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional Roles of miR-34a in Cancer: A Review with the Emphasis on Head and Neck Squamous Cell Carcinoma and Thyroid Cancer with Clinical Implications.
    Kalfert D; Ludvikova M; Pesta M; Ludvik J; Dostalova L; Kholová I
    Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32764498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-34a promotes MICB expression in hepatocytes.
    Zhou MT; Zhao C; Chen X; Zhang HC; Li G; Lou H; Huang WJ; Wei LJ; Li DW; Wu X; Zhang ZC; Liu H; Ou R; Yang WJ; Hu S; Xu Y; Tang KF
    Carcinogenesis; 2018 Dec; 39(12):1477-1487. PubMed ID: 30256916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.
    Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ
    BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systemic Review on the Regulatory Roles of miR-34a in Gastrointestinal Cancer.
    Kong J; Wang W
    Onco Targets Ther; 2020; 13():2855-2872. PubMed ID: 32308419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-34a regulates HDAC1 expression to affect the proliferation and apoptosis of hepatocellular carcinoma.
    Sun TY; Xie HJ; Li Z; Kong LF; Gou XN; Li DJ; Shi YJ; Ding YZ
    Am J Transl Res; 2017; 9(1):103-114. PubMed ID: 28123637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A High-Throughput Small Molecule Screen Identifies Ouabain as Synergistic with miR-34a in Killing Lung Cancer Cells.
    Rupaimoole R; Yoon B; Zhang WC; Adams BD; Slack FJ
    iScience; 2020 Feb; 23(2):100878. PubMed ID: 32062455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment.
    Yang F; Li QJ; Gong ZB; Zhou L; You N; Wang S; Li XL; Li JJ; An JZ; Wang DS; He Y; Dou KF
    Technol Cancer Res Treat; 2014 Feb; 13(1):77-86. PubMed ID: 23862748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of miR-34a in p53 deficient cells unexpectedly promotes the cell survival by increasing NFκB activity.
    Tan J; Fan L; Mao JJ; Chen B; Zheng L; Zhang T; Li T; Duan J; Duan Y; Jin Z; Kuang W
    J Cell Biochem; 2012 Sep; 113(9):2903-8. PubMed ID: 22531959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.